Strong T cell type-1 immune responses to HIV-1 Tat (1–72) protein-coated nanoparticles
- 30 June 2004
- Vol. 22 (20) , 2631-2640
- https://doi.org/10.1016/j.vaccine.2003.12.013
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Tat-Vaccinated Macaques Do Not Control Simian Immunodeficiency Virus SIVmac239 ReplicationJournal of Virology, 2002
- HIV-1 Tat: coping with negative elongation factorsCurrent Opinion in Immunology, 1999
- The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection.Journal of Clinical Investigation, 1998
- Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAScience, 1998
- Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patientsGene Therapy, 1997
- Induction of Apoptosis in Uninfected Lymphocytes by HIV-1 Tat ProteinScience, 1995
- Structural studies of HIV-1 tat proteinJournal of Molecular Biology, 1995
- CONTROL OF RNA INITIATION AND ELONGATION AT THE HIV-1 PROMOTERAnnual Review of Biochemistry, 1994
- Inhibition of Antigen-Induced Lymphocyte Proliferation by Tat Protein from HIV-1Science, 1989
- Cellular uptake of the tat protein from human immunodeficiency virusCell, 1988